List of Tables
    Table 1. Inflammatory Bowel Disease Drugs CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Inflammatory Bowel Disease Drugs Market Trends
    Table 3. Inflammatory Bowel Disease Drugs Market Drivers
    Table 4. Inflammatory Bowel Disease Drugs Market Challenges
    Table 5. Inflammatory Bowel Disease Drugs Market Restraints
    Table 6. Global Inflammatory Bowel Disease Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Inflammatory Bowel Disease Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Inflammatory Bowel Disease Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Inflammatory Bowel Disease Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Inflammatory Bowel Disease Drugs Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Inflammatory Bowel Disease Drugs Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Inflammatory Bowel Disease Drugs Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Inflammatory Bowel Disease Drugs Sales by Manufacturer, (K Units), 2017-2022
    Table 14. Global Inflammatory Bowel Disease Drugs Sales Share by Manufacturer, 2017-2022
    Table 15. Global Inflammatory Bowel Disease Drugs Price by Manufacturer (2017-2022) & (USD/Unit)
    Table 16. Global Inflammatory Bowel Disease Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Inflammatory Bowel Disease Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inflammatory Bowel Disease Drugs as of 2021)
    Table 18. Top Players of Inflammatory Bowel Disease Drugs in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Inflammatory Bowel Disease Drugs Product Type
    Table 20. Date of International Manufacturers Enter into Inflammatory Bowel Disease Drugs Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Inflammatory Bowel Disease Drugs Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Inflammatory Bowel Disease Drugs Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Inflammatory Bowel Disease Drugs Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Inflammatory Bowel Disease Drugs Sales by Players, (K Units), 2020, 2021 & 2022
    Table 26. United States Inflammatory Bowel Disease Drugs Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Inflammatory Bowel Disease Drugs Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Inflammatory Bowel Disease Drugs Sales in Volume by Region (2017-2022) & (K Units)
    Table 29. Global Inflammatory Bowel Disease Drugs Sales in Volume Forecast by Region (2023-2028) & (K Units)
    Table 30. Global Inflammatory Bowel Disease Drugs Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Inflammatory Bowel Disease Drugs Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Inflammatory Bowel Disease Drugs Sales in Volume by Country (2017-2028) & (K Units)
    Table 33. North America Inflammatory Bowel Disease Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Inflammatory Bowel Disease Drugs Sales in Volume by Region (2017-2028) & (K Units)
    Table 35. Asia Pacific Inflammatory Bowel Disease Drugs Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Inflammatory Bowel Disease Drugs Sales in Volume by Country (2017-2028) & (K Units)
    Table 37. Europe Inflammatory Bowel Disease Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Inflammatory Bowel Disease Drugs Sales in Volume by Country (2017-2028) & (K Units)
    Table 39. Latin Americaa Inflammatory Bowel Disease Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Inflammatory Bowel Disease Drugs Sales in Volume by Country (2017-2028) & (K Units)
    Table 41. Middle East and Africa Inflammatory Bowel Disease Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Abbott Laboratories Corporation Information
    Table 43. Abbott Laboratories Description and Business Overview
    Table 44. Abbott Laboratories Inflammatory Bowel Disease Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 45. Abbott Laboratories Inflammatory Bowel Disease Drugs Product
    Table 46. Abbott Laboratories Recent Development
    Table 47. Biocon Ltd Corporation Information
    Table 48. Biocon Ltd Description and Business Overview
    Table 49. Biocon Ltd Inflammatory Bowel Disease Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 50. Biocon Ltd Product
    Table 51. Biocon Ltd Recent Development
    Table 52. Roche Corporation Information
    Table 53. Roche Description and Business Overview
    Table 54. Roche Inflammatory Bowel Disease Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 55. Roche Product
    Table 56. Roche Recent Development
    Table 57. Johnson and Johnson Corporation Information
    Table 58. Johnson and Johnson Description and Business Overview
    Table 59. Johnson and Johnson Inflammatory Bowel Disease Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 60. Johnson and Johnson Product
    Table 61. Johnson and Johnson Recent Development
    Table 62. Mylan Pharmaceuticals Corporation Information
    Table 63. Mylan Pharmaceuticals Description and Business Overview
    Table 64. Mylan Pharmaceuticals Inflammatory Bowel Disease Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 65. Mylan Pharmaceuticals Product
    Table 66. Mylan Pharmaceuticals Recent Development
    Table 67. Novartis AG Corporation Information
    Table 68. Novartis AG Description and Business Overview
    Table 69. Novartis AG Inflammatory Bowel Disease Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 70. Novartis AG Product
    Table 71. Novartis AG Recent Development
    Table 72. Pfizer Corporation Information
    Table 73. Pfizer Description and Business Overview
    Table 74. Pfizer Inflammatory Bowel Disease Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 75. Pfizer Product
    Table 76. Pfizer Recent Development
    Table 77. Quest Medical Corporation Information
    Table 78. Quest Medical Description and Business Overview
    Table 79. Quest Medical Inflammatory Bowel Disease Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 80. Quest Medical Product
    Table 81. Quest Medical Recent Development
    Table 82. Sanofi Corporation Information
    Table 83. Sanofi Description and Business Overview
    Table 84. Sanofi Inflammatory Bowel Disease Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 85. Sanofi Product
    Table 86. Sanofi Recent Development
    Table 87. Takeda Pharmaceutical Corporation Information
    Table 88. Takeda Pharmaceutical Description and Business Overview
    Table 89. Takeda Pharmaceutical Inflammatory Bowel Disease Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 90. Takeda Pharmaceutical Product
    Table 91. Takeda Pharmaceutical Recent Development
    Table 92. Key Raw Materials Lists
    Table 93. Raw Materials Key Suppliers Lists
    Table 94. Inflammatory Bowel Disease Drugs Customers List
    Table 95. Inflammatory Bowel Disease Drugs Distributors List
    Table 96. Research Programs/Design for This Report
    Table 97. Key Data Information from Secondary Sources
    Table 98. Key Data Information from Primary Sources
List of Figures
    Figure 1. Inflammatory Bowel Disease Drugs Product Picture
    Figure 2. Global Inflammatory Bowel Disease Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Inflammatory Bowel Disease Drugs Market Size 2017-2028 (US$ Million)
    Figure 4. Global Inflammatory Bowel Disease Drugs Sales 2017-2028 (K Units)
    Figure 5. United States Inflammatory Bowel Disease Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Inflammatory Bowel Disease Drugs Market Size 2017-2028 (US$ Million)
    Figure 7. United States Inflammatory Bowel Disease Drugs Sales 2017-2028 (K Units)
    Figure 8. United States Inflammatory Bowel Disease Drugs Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Inflammatory Bowel Disease Drugs Market Share in Global, in Volume (K Units) 2017-2028
    Figure 10. Inflammatory Bowel Disease Drugs Report Years Considered
    Figure 11. Product Picture of Amino-salicylates
    Figure 12. Product Picture of Antibiotics
    Figure 13. Product Picture of Corticosteroids
    Figure 14. Product Picture of Immunomodulators
    Figure 15. Product Picture of Biologics
    Figure 16. Product Picture of Others
    Figure 17. Global Inflammatory Bowel Disease Drugs Market Share by Type in 2022 & 2028
    Figure 18. Global Inflammatory Bowel Disease Drugs Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 19. Global Inflammatory Bowel Disease Drugs Sales Market Share in Value by Type (2017-2028)
    Figure 20. Global Inflammatory Bowel Disease Drugs Sales by Type (2017-2028) & (K Units)
    Figure 21. Global Inflammatory Bowel Disease Drugs Sales Market Share in Volume by Type (2017-2028)
    Figure 22. Global Inflammatory Bowel Disease Drugs Price by Type (2017-2028) & (USD/Unit)
    Figure 23. United States Inflammatory Bowel Disease Drugs Market Share by Type in 2022 & 2028
    Figure 24. United States Inflammatory Bowel Disease Drugs Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 25. United States Inflammatory Bowel Disease Drugs Sales Market Share in Value by Type (2017-2028)
    Figure 26. United States Inflammatory Bowel Disease Drugs Sales by Type (2017-2028) & (K Units)
    Figure 27. United States Inflammatory Bowel Disease Drugs Sales Market Share in Volume by Type (2017-2028)
    Figure 28. United States Inflammatory Bowel Disease Drugs Price by Type (2017-2028) & (USD/Unit)
    Figure 29. Product Picture of Ulcerative Colitis
    Figure 30. Product Picture of Crohns Disease
    Figure 31. Product Picture of Indeterminate Colitis
    Figure 32. Product Picture of Others
    Figure 33. Global Inflammatory Bowel Disease Drugs Market Share by Application in 2022 & 2028
    Figure 34. Global Inflammatory Bowel Disease Drugs Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 35. Global Inflammatory Bowel Disease Drugs Sales Market Share in Value by Application (2017-2028)
    Figure 36. Global Inflammatory Bowel Disease Drugs Sales by Application (2017-2028) & (K Units)
    Figure 37. Global Inflammatory Bowel Disease Drugs Sales Market Share in Volume by Application (2017-2028)
    Figure 38. Global Inflammatory Bowel Disease Drugs Price by Application (2017-2028) & (USD/Unit)
    Figure 39. United States Inflammatory Bowel Disease Drugs Market Share by Application in 2022 & 2028
    Figure 40. United States Inflammatory Bowel Disease Drugs Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 41. United States Inflammatory Bowel Disease Drugs Sales Market Share in Value by Application (2017-2028)
    Figure 42. United States Inflammatory Bowel Disease Drugs Sales by Application (2017-2028) & (K Units)
    Figure 43. United States Inflammatory Bowel Disease Drugs Sales Market Share in Volume by Application (2017-2028)
    Figure 44. United States Inflammatory Bowel Disease Drugs Price by Application (2017-2028) & (USD/Unit)
    Figure 45. North America Inflammatory Bowel Disease Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 46. North America Inflammatory Bowel Disease Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 47. U.S. Inflammatory Bowel Disease Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Canada Inflammatory Bowel Disease Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Europe Inflammatory Bowel Disease Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 50. Europe Inflammatory Bowel Disease Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 51. Germany Inflammatory Bowel Disease Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. France Inflammatory Bowel Disease Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 53. U.K. Inflammatory Bowel Disease Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Italy Inflammatory Bowel Disease Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Russia Inflammatory Bowel Disease Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. Asia-Pacific Inflammatory Bowel Disease Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 57. Asia-Pacific Inflammatory Bowel Disease Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 58. China Inflammatory Bowel Disease Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Japan Inflammatory Bowel Disease Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. South Korea Inflammatory Bowel Disease Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. India Inflammatory Bowel Disease Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Australia Inflammatory Bowel Disease Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Taiwan Inflammatory Bowel Disease Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Indonesia Inflammatory Bowel Disease Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Thailand Inflammatory Bowel Disease Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Malaysia Inflammatory Bowel Disease Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Philippines Inflammatory Bowel Disease Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Latin America Inflammatory Bowel Disease Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 69. Latin America Inflammatory Bowel Disease Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 70. Mexico Inflammatory Bowel Disease Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. Brazil Inflammatory Bowel Disease Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. Argentina Inflammatory Bowel Disease Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. Middle East & Africa Inflammatory Bowel Disease Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 74. Middle East & Africa Inflammatory Bowel Disease Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 75. Turkey Inflammatory Bowel Disease Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 76. Saudi Arabia Inflammatory Bowel Disease Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 77. U.A.E Inflammatory Bowel Disease Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 78. Inflammatory Bowel Disease Drugs Value Chain
    Figure 79. Inflammatory Bowel Disease Drugs Production Process
    Figure 80. Channels of Distribution
    Figure 81. Distributors Profiles
    Figure 82. Bottom-up and Top-down Approaches for This Report
    Figure 83. Data Triangulation
    Figure 84. Key Executives Interviewed